Compile Data Set for Download or QSAR
maximum 50k data
Found 17 with Last Name = 'yokomoto' and Initial = 'm'
LigandPNGBDBM50287294(2-[5-Ethyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylm...)
Affinity DataIC50:  0.440nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50287290(CHEMBL34866 | KRH-594 | Potassium; 2-[5-ethyl-3-[2...)
Affinity DataIC50:  0.440nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50287291(CHEMBL35381 | N-[5-Ethyl-3-[2'-(1H-tetrazol-5-yl)-...)
Affinity DataIC50:  0.660nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50287289(2-Chloro-N-[5-ethyl-3-[2'-(1H-tetrazol-5-yl)-biphe...)
Affinity DataIC50:  3.60nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50287292(CHEMBL34190 | Cyclopropanecarboxylic acid [5-ethyl...)
Affinity DataIC50:  6.5nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50287295(CHEMBL35475 | N-[5-Ethyl-3-[2'-(1H-tetrazol-5-yl)-...)
Affinity DataIC50:  7.20nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
LigandPNGBDBM50406795(Cozaar | LOSARTAN POTASSIUM)
Affinity DataIC50:  9.80nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
TargetMitogen-activated protein kinase 13(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50:  11nMAssay Description:Inhibition of human MAPK p38alpha by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 11(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50:  36nMAssay Description:Inhibition of human MAPK p38beta by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50287293(CHEMBL286537 | N-[5-Ethyl-3-[2'-(1H-tetrazol-5-yl)...)
Affinity DataIC50:  37nMAssay Description:Compound was tested in vitro for the ability to displace the specific binding of [125I]-A II from receptors in rat liver membrane(type 1 receptor)More data for this Ligand-Target Pair
In DepthDetails Article
TargetMitogen-activated protein kinase 9(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human recombinant JNK2alpha2-mediated ATF-2 phosphorylation after 30 mins by immunoblotting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50:  1.90E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human ERG by Rb ion flux assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50396845(CHEMBL2170294)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of CYP3A4 using midazolam as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed